Published in Diabet Med on November 01, 1993
Cardiovascular autonomic neuropathies as complications of diabetes mellitus. Nat Rev Endocrinol (2012) 1.36
Diabetic cardiomyopathy: from the pathophysiology of the cardiac myocytes to current diagnosis and management strategies. Vasc Health Risk Manag (2010) 1.24
Long-term mortality in nationwide cohorts of childhood-onset type 1 diabetes in Japan and Finland. Diabetes Care (2003) 1.21
Cardiac autonomic neuropathy in patients with diabetes mellitus. World J Diabetes (2014) 1.19
Diabetic neuropathy. Postgrad Med J (2006) 1.16
Type 2 diabetes mellitus and the risk of sudden cardiac arrest in the community. Rev Endocr Metab Disord (2010) 1.11
Circadian rhythm of the autonomic nervous system in insulin resistant subjects with normoglycemia, impaired fasting glycemia, impaired glucose tolerance, type 2 diabetes mellitus. BMC Cardiovasc Disord (2006) 1.10
Diabetes and cardiac autonomic neuropathy: Clinical manifestations, cardiovascular consequences, diagnosis and treatment. World J Diabetes (2015) 1.08
Cardiovascular autonomic dysfunction in sickle cell anemia: a possible risk factor for sudden death? Clin Auton Res (1997) 1.07
Sudden cardiac death in diabetes mellitus: risk factors in the Rochester diabetic neuropathy study. J Neurol Neurosurg Psychiatry (2005) 1.05
Advances in diabetes for the millennium: new treatments for diabetic neuropathies. MedGenMed (2004) 1.00
Cardiovascular autonomic neuropathy and subclinical cardiovascular disease in normoalbuminuric type 1 diabetic patients. Diabetes (2012) 0.93
Reduced heart rate variability is associated with increased arterial stiffness in youth with type 1 diabetes: the SEARCH CVD study. Diabetes Care (2013) 0.92
Effect of diabetes on serum potassium concentrations in acute coronary syndromes. Heart (2003) 0.88
A pharmacologic pupillary test in the diagnosis of diabetic autonomic neuropathy. Korean J Ophthalmol (2009) 0.82
Plantar thermography is useful in the early diagnosis of diabetic neuropathy. Clinics (Sao Paulo) (2012) 0.82
Reappraisal of the diagnostic role of orthostatic hypotension in diabetes. Clin Auton Res (2009) 0.81
Molecular network-based analysis of guizhi-shaoyao-zhimu decoction, a TCM herbal formula, for treatment of diabetic peripheral neuropathy. Acta Pharmacol Sin (2015) 0.81
The management of diabetic neuropathy in CKD. Am J Kidney Dis (2009) 0.79
The cost of diabetic neuropathy. Pharmacoeconomics (1995) 0.79
Development of a new method for assessing the cardiac baroreflex: response to downward tilting in patients with diabetes mellitus. Heart (2001) 0.78
Relationship between the Korean Version Survey of the Autonomic Symptoms Score and Cardiac Autonomic Neuropathy Parameters in Patients with Diabetic Peripheral Neuropathy. Diabetes Metab J (2014) 0.78
Cardiovascular autonomic neuropathy in type 2 diabetes mellitus patients with peripheral artery disease. Diabetol Metab Syndr (2013) 0.78
New squatting test indices are useful for assessing baroreflex sensitivity in diabetes mellitus. Diabet Med (2008) 0.78
Autonomic neuropathy in asymptomatic subjects with non-insulin-dependent diabetes mellitus and microalbuminuria. Clin Auton Res (1998) 0.76
Effects of metabolic and myocardial microcirculatory abnormalities on the pathogenesis of cardiac autonomic neuropathy in type 2 diabetes mellitus: A prospective study in Japanese patients. Curr Ther Res Clin Exp (2005) 0.75
Prevalence of cardiac autonomic neuropathy in Asian Indian patients with fibrocalculous pancreatic diabetes. Indian J Endocrinol Metab (2012) 0.75
Pupil cycle time and contrast sensitivity in type II diabetes mellitus patients: a pilot study. Indian J Ophthalmol (2011) 0.75
Clinical evaluation of vasomotor system functionality in type 2 diabetic Patients. Caspian J Intern Med (2017) 0.75
Novel Measure of Autonomic Remodeling Associated with Sudden Cardiac Arrest in Diabetes. Heart Rhythm (2017) 0.75
Cross-spectral analysis of cardiovascular variables in supine diabetic patients. Clin Auton Res (2005) 0.75
Impaired autonomic function in type 2 diabetic patients during upper gastrointestinal endoscopy. J Gastroenterol (2008) 0.75
MDCT assessment of CAD in type-2 diabetic subjects with diabetic neuropathy: the role of Charcot neuro-arthropathy. Eur Radiol (2015) 0.75
A desktop guide for the management of non-insulin-dependent diabetes mellitus (NIDDM): an update. European NIDDM Policy Group. Diabet Med (1994) 2.78
High prevalence of undiagnosed diabetes mellitus in Southern Germany: target populations for efficient screening. The KORA survey 2000. Diabetologia (2003) 2.73
Management of non-insulin-dependent diabetes mellitus in Europe: a concensus view. Diabet Med (1988) 2.27
Standardized tests of heart rate variability: normal ranges obtained from 309 healthy humans, and effects of age, gender, and heart rate. Clin Auton Res (2001) 2.10
Trend of hip fracture incidence in Germany 1995-2004: a population-based study. Osteoporos Int (2007) 1.90
Effects of treatment with the antioxidant alpha-lipoic acid on cardiac autonomic neuropathy in NIDDM patients. A 4-month randomized controlled multicenter trial (DEKAN Study). Deutsche Kardiale Autonome Neuropathie. Diabetes Care (1997) 1.84
Prevalence of lipohypertrophy in insulin-treated diabetic patients and predisposing factors. Exp Clin Endocrinol Diabetes (1996) 1.83
Assessment of cardiovascular autonomic function: age-related normal ranges and reproducibility of spectral analysis, vector analysis, and standard tests of heart rate variation and blood pressure responses. Diabet Med (1992) 1.80
Transfer of insulin-dependent diabetes between HLA-identical siblings by bone marrow transplantation. Lancet (1993) 1.68
[Quality of care and extent of complications in a population-based sample of patients with type 2 diabetes mellitus. The KORA Survey 2000]. Dtsch Med Wochenschr (2006) 1.64
Treatment of symptomatic diabetic peripheral neuropathy with the anti-oxidant alpha-lipoic acid. A 3-week multicentre randomized controlled trial (ALADIN Study). Diabetologia (1995) 1.63
Age- and sex-specific incidence rates of migraine with and without visual aura. Am J Epidemiol (1991) 1.62
Autonomic imbalance: prophet of doom or scope for hope? Diabet Med (2011) 1.57
An epidemiologic study of headache among adolescents and young adults. JAMA (1989) 1.57
[Drug prescriptions and costs in diabetic polyneuropathy]. Dtsch Med Wochenschr (1999) 1.49
Impaired glucose tolerance is associated with increased serum concentrations of interleukin 6 and co-regulated acute-phase proteins but not TNF-alpha or its receptors. Diabetologia (2002) 1.49
Autoantibodies to the islet antigen ICA69 occur in IDDM and in rheumatoid arthritis. Diabetologia (1995) 1.48
Incidence of lower-limb amputations in the diabetic compared to the non-diabetic population. findings from nationwide insurance data, Germany, 2005-2007. Exp Clin Endocrinol Diabetes (2009) 1.45
Guidelines for the diagnosis and outpatient management of diabetic peripheral neuropathy. Diabet Med (1998) 1.43
Long-term experience with an ultrapure individual dialysis fluid with a batch type machine. Nephrol Dial Transplant (1998) 1.40
Control of chromosome behavior in amphibian oocytes. I. The activity of maturing oocytes inducing chromosome condensation in transplanted brain nuclei. Dev Biol (1973) 1.40
Changes in brainstem auditory evoked potentials during insulin-induced hypoglycaemia in type 1 diabetic patients. Diabet Med (1991) 1.39
Exercise-induced fall of blood glucose in insulin-treated diabetics unrelated to alteration of insulin mobilization. Diabetes (1979) 1.33
Assessment of small and large fiber function in long-term type 1 (insulin-dependent) diabetic patients with and without painful neuropathy. Pain (1988) 1.28
The epidemiology of diabetic neuropathy. Diabetic Cardiovascular Autonomic Neuropathy Multicenter Study Group. J Diabetes Complications (1992) 1.27
Sex differences in the associations of socioeconomic status with undiagnosed diabetes mellitus and impaired glucose tolerance in the elderly population: the KORA Survey 2000. Eur J Public Health (2005) 1.26
Parylene flexible neural probes integrated with microfluidic channels. Lab Chip (2005) 1.24
Asymmetry of gait initiation in hemiparetic stroke subjects. Arch Phys Med Rehabil (1997) 1.21
Large platelets circulate in an activated state in diabetes mellitus. Semin Thromb Hemost (1991) 1.19
Metabolic and hormonal effects of muscular exercise in juvenile type diabetics. Diabetologia (1977) 1.17
Septicemia in 980 patients at a university hospital in Berlin: prospective studies during 4 selected years between 1979 and 1989. Clin Infect Dis (1992) 1.17
Evaluation of matrix-assisted laser desorption/ionization time of flight mass spectrometry for characterization of Culicoides nubeculosus biting midges. Med Vet Entomol (2010) 1.15
Systemic bias of cytokine production toward cell-mediated immune regulation in IDDM and toward humoral immunity in Graves' disease. Diabetes (1997) 1.13
Alpha-lipoic acid in the treatment of diabetic polyneuropathy in Germany: current evidence from clinical trials. Exp Clin Endocrinol Diabetes (1999) 1.13
Visceral afferent neuropathy in diabetic gastroparesis. Diabetes Care (1991) 1.13
PTCA: periprocedural platelet activation. Part II of the Duesseldorf PTCA platelet study (DPPS) Eur Heart J (1996) 1.12
Evidence for abnormal platelet glycoprotein expression in diabetes mellitus. Eur J Clin Invest (1990) 1.11
Positive neuropathic sensory symptoms as endpoints in diabetic neuropathy trials. J Neurol Sci (2001) 1.10
Selective contribution of diabetes and other cardiovascular risk factors to cardiac autonomic dysfunction in the general population. Exp Clin Endocrinol Diabetes (2006) 1.07
Evaluation of thermal, pain, and vibration sensation thresholds in newly diagnosed type 1 diabetic patients. J Neurol Neurosurg Psychiatry (1988) 1.06
Prevalence of gastrointestinal symptoms in diabetic patients and non-diabetic subjects. Z Gastroenterol (1994) 1.05
Incidence of lower limb amputations and diabetes. Diabetes Care (1996) 1.05
Inflammation and type 2 diabetes: results from KORA Augsburg. Gesundheitswesen (2005) 1.04
Hepatic production of VLDL-triglycerides. Dependence of portal substrate and insulin concentration. Horm Metab Res (1980) 1.04
Dietary-induced hypertrophic--hyperplastic obesity in mice. J Lipid Res (1974) 1.04
Noninvasive blood glucose sensors based on near-infrared spectroscopy. Artif Organs (1994) 1.04
Low faecal elastase 1 concentrations in type 2 diabetes mellitus. Scand J Gastroenterol (2001) 1.04
Unchanged incidence of lower-limb amputations in a German City, 1990-1998. Diabetes Care (2001) 1.02
[13C]octanoic acid breath test for non-invasive assessment of gastric emptying in diabetic patients: validation and relationship to gastric symptoms and cardiovascular autonomic function. Diabetologia (1996) 1.01
Nutritional intake of 2868 IDDM patients from 30 centres in Europe. EURODIAB IDDM Complications Study Group. Diabetologia (1996) 1.01
High prevalence of undiagnosed impaired glucose regulation and diabetes mellitus in patients scheduled for an elective coronary angiography. Clin Res Cardiol (2006) 0.97
Platelet membrane activation markers are predictive for increased risk of acute ischemic events after PTCA. Circulation (1993) 0.97
The adenosine A1 receptor antagonist SLV320 reduces myocardial fibrosis in rats with 5/6 nephrectomy without affecting blood pressure. Br J Pharmacol (2007) 0.97
Control of chromosome behavior in amphibian oocytes. II. The effect of inhibitors of RNA and protein synthesis on the induction of chromosome condensation in transplanted brain nuclei by oocyte cytoplasm. J Cell Biol (1976) 0.97
Alpha-lipoic acid in the treatment of diabetic peripheral and cardiac autonomic neuropathy. Diabetes (1997) 0.96
The Deutsche Nicotinamide Intervention Study: an attempt to prevent type 1 diabetes. DENIS Group. Diabetes (1998) 0.96
Interferometric coupling of the Keck telescopes with single-mode fibers. Science (2006) 0.96
Corneal confocal microscopy: a new technique for early detection of diabetic neuropathy. Curr Diab Rep (2013) 0.95
Effects of the carnitine-acyltransferase inhibitor etomoxir on insulin sensitivity, energy expenditure and substrate oxidation in NIDDM. Horm Metab Res (1997) 0.95
Flow-cytometric detection of surface membrane alterations and concomitant changes in the cytoskeletal actin status of activated platelets. Cytometry (1990) 0.95
Effects of 3-week oral treatment with the antioxidant thioctic acid (alpha-lipoic acid) in symptomatic diabetic polyneuropathy. Diabet Med (1999) 0.94
Sildenafil citrate for the treatment of erectile dysfunction in men with Type II diabetes mellitus. Diabetologia (2001) 0.94
Incidence of blindness in relation to diabetes. A population-based study. Diabetes Care (1997) 0.94
Novel pyrogen tests based on the human fever reaction. The report and recommendations of ECVAM Workshop 43. European Centre for the Validation of Alternative Methods. European Centre for the Validation of Alternative Methods. Altern Lab Anim (2001) 0.94
The epidemiology of diabetic neuropathy. DiaCAN Multicenter Study Group. Diabet Med (1993) 0.94
Prevalence and clinical correlates of cardiovascular autonomic and peripheral diabetic neuropathy in patients attending diabetes centers. The Diacan Multicenter Study Group. Diabete Metab (1993) 0.94
Blindness due to diabetes: population-based age- and sex-specific incidence rates. Diabet Med (1997) 0.94
Blood amine acid levels in patients with insulin excess (functioning insulinoma) and insulin deficiency (diabetic ketosis). Metabolism (1978) 0.93
Plasma concentrations of soluble TNF-alpha receptors in obese subjects. Int J Obes Relat Metab Disord (1998) 0.93
Direct costs of pediatric diabetes care in Germany and their predictors. Exp Clin Endocrinol Diabetes (2004) 0.92
Efficacy and safety of pregabalin in treatment refractory patients with various neuropathic pain entities in clinical routine. Int J Clin Pract (2007) 0.92
Sit-to-stand manoeuvre in hemiparetic patients before and after a 4-week rehabilitation programme. Scand J Rehabil Med (1998) 0.92
HLA antigens and immunoresponsiveness to insulin in insulin-dependent diabetes mellitus. Tissue Antigens (1976) 0.92
A simple new non-invasive sweat indicator test for the diagnosis of diabetic neuropathy. Diabet Med (2013) 0.92
Evidence of IgG autoantibodies against human proinsulin in patients with IDDM before insulin treatment. Diabetes (1988) 0.92
The natural course of peripheral and autonomic neural function during the first two years after diagnosis of type 1 diabetes. Klin Wochenschr (1988) 0.91
Glucose metabolism in perfused skeletal muscle. Demonstration of insulin resistance in the obese Zucker rat. Biochem J (1979) 0.91
[1H-NMR-spectroscopic evidence for the release of N-acetyl-alpha-D-neuraminic acid as the first product of neuraminidase action (author's transl)]. Hoppe Seylers Z Physiol Chem (1980) 0.91
Quantitative analysis of rising from a chair in healthy and hemiparetic subjects. Scand J Rehabil Med (1994) 0.91
Clinical and cost-effectiveness of primary prevention of Type 2 diabetes in a 'real world' routine healthcare setting: model based on the KORA Survey 2000. Diabet Med (2007) 0.91
Association of elevated serum uric acid with coronary heart disease in diabetes mellitus. Diabete Metab (1993) 0.89
Follow-up of cyclosporin A treatment in type 1 (insulin-dependent) diabetes mellitus: lack of long-term effects. Diabetologia (1991) 0.89
Phenotyping animal models of diabetic neuropathy: a consensus statement of the diabetic neuropathy study group of the EASD (Neurodiab). J Peripher Nerv Syst (2014) 0.89
Low fecal elastase-1 in type I diabetes mellitus. Z Gastroenterol (2001) 0.88
Proinsulin autoantibodies are more closely associated with type 1 (insulin-dependent) diabetes mellitus than insulin autoantibodies. Diabetologia (1991) 0.88
Cerebral glucose metabolism in type 1 diabetic patients. Diabet Med (1994) 0.88
Prevalence of functional bowel disorders and related health care seeking: a population-based study. Z Gastroenterol (2002) 0.88
Prescription drug use and costs among diabetic patients in primary health care practices in Germany. Diabetes Care (1998) 0.87
Cardiovascular autonomic neuropathy contributes to left ventricular diastolic dysfunction in subjects with Type 2 diabetes and impaired glucose tolerance undergoing coronary angiography. Diabet Med (2011) 0.87
The natural history of somatosensory and autonomic nerve dysfunction in relation to glycaemic control during the first 5 years after diagnosis of type 1 (insulin-dependent) diabetes mellitus. Diabetologia (1991) 0.87
Differences in the development of the obese-hyperglycemic syndrome in obob and NZO mice. Diabetologia (1970) 0.87
Medical strategies to reduce amputation in patients with type 2 diabetes. Diabet Med (2013) 0.86
The metabolic syndrome sensitizes leukocytes for glucose-induced immune gene expression. J Mol Med (Berl) (2006) 0.86
Differential association of adiponectin with cardiovascular risk markers in men and women? The KORA survey 2000. Int J Obes (Lond) (2006) 0.86
Aberrant stress response associated with severe hypoglycemia in a transgenic mouse model of Alzheimer's disease. J Mol Neurosci (2000) 0.86
Hospitalization among diabetic children and adolescents and non-diabetic control subjects: a prospective population-based study. Diabetologia (2001) 0.86
Platelets in diabetes: the role in the hemostatic regulation in atherosclerosis. Semin Thromb Hemost (1993) 0.86